Mechanisms of inhibition of the host interferon α/β-mediated antiviral responses by viruses

Microbes and Infection

Volumn 4, Issue 6, 2002, Pages 647-655

  García Sastre, Adolfo ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Innate immunity; Interferon; Interferon antagonist

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON;

ADENOVIRUS; ANTIVIRAL ACTIVITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOMEGALOVIRUS; EBOLA VIRUS; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HERPES VIRUS; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION CONTROL; INFLUENZA VIRUS; MEASLES VIRUS; MUMPS VIRUS; NONHUMAN; PARAINFLUENZA VIRUS; PARAMYXOVIRUS; POLIOMYELITIS VIRUS; POXVIRUS; PRIORITY JOURNAL; PROTEIN INDUCTION; REGULATORY MECHANISM; REOVIRUS; REVIEW; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION; WART VIRUS;

EID: 0036284737     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01583-6     Document Type: Article

References (93)

1. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo
2. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3
3. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7
4. The human interferon alpha/beta receptor: Characterization and molecular cloning
5. P135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor
6. How cells respond to interferons
7. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays
8. PKR; A sentinel kinase for cellular stress
9. The human 2′,5′-oligoadenylate synthetase family: Interferon-induced proteins with unique enzymatic properties
10. Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L
11. A specific isozyme of 2′-5′ oligoadenylate synthetase is a dual function proapoptotic protein of the Bcl-2 family
12. Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins
13. GTPase blocks reporter gene expression of reconstituted Thogoto virus ribonucleoprotein complexes
14. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein
15. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus
16. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator
17. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption
18. Mechanism of interferon action: Functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase
19. A new pathway of translational regulation mediated by eukaryotic initiation factor 3
20. Interferon treatment of mice: Enhanced expression of histocompatibility antigens on lymphoid cells
21. Gene induction pathways mediated by distinct IRFs during viral infection
22. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity
23. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling
24. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase
25. When two strands are better than one: The mediators and modulators of the cellular responses to double-stranded RNA
26. Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: Role of complex formation and the E3 N-terminal domain
27. The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: Implications for PKR autoregulation
28. IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or IκB kinase but is blocked by vaccinia virus E3L protein
29. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2
30. Vaccinia virus-encoded eIF-2α homolog abrogates the antiviral effect of interferon
31. The γ(1) 34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase
32. A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function
33. The herpes simplex virus US11 protein effectively compensates for the γ1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the α subunit of eukaryotic translation initiation factor 2
34. Activation of the ppp(A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA-dependent RNase
35. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: Induction of interferon-responsive RNAs
36. Cellular gene expression altered by human cytomegalovirus: Global monitoring with oligonucleotide arrays
37. Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B
38. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway
39. Human cytomegalovirus inhibits IFN-α-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-α signal transduction
40. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription
41. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor
42. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors
43. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300
44. Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor
45. Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase
46. Adenovirus virus-associated RNA and translation control
47. Restoration of interferon responses of adenovirus E1A-expressing HT1080 cell lines by overexpression of p48 protein
48. Direct suppression of Stat1 function during adenoviral infection
49. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region
50. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation
51. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein
52. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems
53. Binding of influenza A virus NS1 protein to dsRNA in vitro
54. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor
55. Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells
56. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication
57. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein
58. Influenza A virus NS1 protein prevents the activation of NF-κB and induction of type I IFN
59. Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells
60. Interaction of the interferon-induced PKR protein kinase with inhibitory proteins P58IPK and vaccinia virus K3L is mediated by unique domains: Implications for kinase regulation
61. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein
62. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation
63. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2
64. Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state
65. Sendai virus C proteins must interact directly with cellular components to interfere with interferon action
66. Gotoh, Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription
67. Sendai virus C protein physically associates with Stat1
68. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response
69. Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis
70. Genetic evidence for an interferon-antagonistic function of Rift valley fever virus nonstructural protein NSs
71. The Ebola virus VP35 protein functions as a type I interferon antagonist
72. Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene
73. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA
74. The polyoma virus T antigen interferes with interferon-inducible gene expression
75. The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3
76. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter
77. Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection
78. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon
79. The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production
80. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme
81. Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI
82. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha
83. The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha
84. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product
85. Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase
86. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells
87. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway
88. The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: Implications for translational regulation
89. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 σ3 protein
90. Evasion of host defenses by measles virus: Wild-type measles virus infection interferes with induction of alpha/beta interferon production
91. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response
92. C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon α and γ signal transduction pathway through decrease of STAT-1α